MAM
Dentsu Aegis Network gets new leadership for Happy mcgarrybowen
MUMBAI: In a bid to strengthen its global creative agency mcgarrybowen’s India footprint, Dentsu Aegis Network (DAN) has elevated Samarjit Choudhry to the role of president – happy mcgarrybowen (HMB) India. In addition to this, the global media and marketing communications conglomerate has also entrusted Soumitra Karnik with the additional charge as chief creative officer (CCO).
Choudhry joined the Network in 2017 as COO – Happy mcgarrybowen India. Armed with more than 20 years of experience, he has worked with agencies such as Ogilvy and Leo Burnett. At Leo Burnett, he was the chief growth officer for the group and was also instrumental in setting up Orchard and Black Pencil for them. In addition, he has also worked to create India’s premier comic book content company, Virgin Comics.
Speaking on his appointment, Choudhry said, “mcgarrybowen has a strong philosophy of solving real problems. They truly operate as a media-agnostic agency. In India the foundation for this is already there and the agency has been operating as Happy mcgarrybowen for over 2 years now. My mandate is to take it to the next level. Other than communication, we already have a strong design practice and in conjunction with the other offerings from DAN, today we offer our clients a one stop solution for whatever their needs might be. I look forward to taking the opportunity to take the legacy forward. And all we ask is, ‘Give us your biggest problem’.”
Soumitra Karnik joined the network in 2012. Prior to that, he was an ECD at JWT. In over 11 years spent there, he worked on a variety of clients including Pepsi, Airtel, Nestle, and Hero Honda. Karnik has also worked at Lowe and Percept. Amongst his notable campaigns are the Pepsi ‘Yeh Hai Youngistaan Meri Jaan’, ‘Slice Aamsutra’, ‘Yaari Ki Gaadi’ for Hero Honda Splendour NXG, and the ‘What Makes Us Click’ campaign for Canon, to name a few.
Speaking about the role, Karnik said, “Happy mcgarrybowen is a phenomenal creative brand and has an enviable body of work to prove it. All these years, I have greatly admired them from a distance and I count my blessings for being given this opportunity to be a part of their creative trajectory. I assume this role with utmost confidence only because the culture of HMB will not have it any other way. I shall take my mandate from Gordon Bowen, our Global CCO, in the coming days and will talk about it soon. Personally, I’d like to build a collaborative creative culture where everyone works with everyone and everyone learns from everyone. There is so much talent out there in the world and sometimes all it takes is a simple call to say, ‘Hi, I have this idea and I need you to make it even more amazing’. Most clients deserve a spectacular package. Anything less is just plain misfortune.”
Happy mcgarrybowen India is going to be a key piece in DAN’s India creative strategy.
DAN CEO greater south and chairman & CEO India Ashish Bhasin said, “With its new leadership in place, I am more than confident that the agency is now in extremely able hands. Happy mcgarrybowen has always been a brand to reckon with and I have no doubt that Samarjit and Soumitra, together, will further fuel this brand legacy and help Happy mcgarrybowen scale new heights.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
